Skip to main content
S 1280 118th Congress Senate Science, Technology, Communications Advanced technology and technological innovations Chemistry Congressional oversight Drug trafficking and controlled substances Higher education Research administration and funding Science and engineering education

TRANQ Research Act of 2023

Introduced: April 25, 2023 Introduced by: Cruz, Ted Republican · Texas See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 13, 2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 286.
Dec 13, 2023
Committee on Commerce, Science, and Transportation. Reported by Senator Cantwell with an amendment in the nature of a substitute. Without written report.
May 10, 2023
Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.
Apr 25, 2023
Introduced in Senate
Apr 25, 2023
Read twice and referred to the Committee on Commerce, Science, and Transportation.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 or the TRANQ Research Act of 2023

This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances.

In particular, NIST must support

  • basic measurement science and research, including graduate and postgraduate research;
  • near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance);
  • strategies and voluntary best practices for handling, transporting, and analyzing such substances; and
  • collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities.

The Government Accountability Office must evaluate the capability of the federal government to respond to the threats posed by new psychoactive substances like xylazine, including with respect to available technology and laboratories.

What's happening now December 13, 2023

Placed on Senate Legislative Calendar under General Orders. Calendar No. 286.

 Related & companion bills 1
  • HR 1734 Related bill TRANQ Research Act of 2023
 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 5
All 5 Democratic 3 Republican 2
R
Blackburn, Marsha
Tennessee · Jun 13, 2023
 D
Cantwell, Maria
Washington · Jun 13, 2023
 R
Capito, Shelley Moore
West Virginia · May 31, 2023
 D
Warnock, Raphael G.
Georgia · May 31, 2023
 D
Welch, Peter
Vermont · Apr 25, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1280: TRANQ Research Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-S-1280/
MLA
"S. 1280: TRANQ Research Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-1280/.
Bluebook (legal)
S. 1280, 118th Cong. (2026), https://openamerica.io/bill/118-S-1280/.
Markdown link
[S. 1280: TRANQ Research Act of 2023](https://openamerica.io/bill/118-S-1280/)
Report a problem